Monthly Archives: April 2017

• 

Obesity blamed for rising incidence of kidney cancer in the UK

By Sharon Kell|2017-04-25T07:46:35+00:0025 Apr 2017|Cancer news|

Cancer Research UK has reported that obesity and being overweight are to [...]

Read More

Comments Off on Obesity blamed for rising incidence of kidney cancer in the UK

• 

Cabozantinib for advanced kidney cancer rejected for the second time by NICE

By Sharon Kell|2017-04-20T14:12:29+00:0020 Apr 2017|Drug treatments|

Unfortunately, the National Institute for Health and Care Excellence (NICE) [...]

Read More

Comments Off on Cabozantinib for advanced kidney cancer rejected for the second time by NICE

• 

Advances in kidney cancer drug treatments shake up drug choices

By Sharon Kell|2017-04-10T12:54:57+00:0010 Apr 2017|Drug treatments|

The following article provides a comprehensive summary of the changing [...]

Read More

Comments Off on Advances in kidney cancer drug treatments shake up drug choices

• 

Treatment for hereditary leiomyomatosis renal cell carcinoma (HLRCC): a rare and aggressive form of kidney cancer

By Sharon Kell|2017-04-10T11:46:46+00:0010 Apr 2017|Drug treatments, Subtypes of RCC|

In this video, Dr W. Marston Linehan, chief of the [...]

Read More

Comments Off on Treatment for hereditary leiomyomatosis renal cell carcinoma (HLRCC): a rare and aggressive form of kidney cancer

• 

NHS cost savings plans could cause cancer patients to suffer

By Sharon Kell|2017-04-04T08:34:08+00:004 Apr 2017|Cancer news|

The Times published an article last week reporting on NHS cost savings [...]

Read More

Comments Off on NHS cost savings plans could cause cancer patients to suffer

• 

Next steps on the NHS five-year forward view

By Sharon Kell|2017-04-04T08:17:41+00:004 Apr 2017|Cancer news|

The NHS Five Year Forward View was launched in October [...]

Read More

Comments Off on Next steps on the NHS five-year forward view